Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug

 

Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug

Clearside Biomedical Inc (NASDAQ: CLSD) shares entered penny stock territory Thursday after the company issued an update on what transpired at a meeting with the FDA regarding the new drug application …

More Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug Videos

Leave a Reply